Price
Financials
Consolidated, Rs crore| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 24.79 | 23.01 | 24.36 | 22.30 | 23.70 | 21.15 |
| Expenses | 20.23 | 21.85 | 21.18 | 20.60 | 22.66 | 22.64 |
| Operating Profit | 4.56 | 1.16 | 3.18 | 1.70 | 1.04 | -1.49 |
| OPM % | 18.39% | 5.04% | 13.05% | 7.62% | 4.39% | -7.04% |
| Other Income | 0.05 | 0.22 | 0.19 | 0.38 | 0.23 | 0.76 |
| Interest | 0.39 | 0.46 | 0.45 | 0.35 | 0.43 | 1.06 |
| Depreciation | 0.64 | 0.64 | 0.66 | 0.84 | 0.79 | 0.73 |
| Profit before tax | 3.58 | 0.28 | 2.26 | 0.89 | 0.05 | -2.52 |
| Tax % | 28.49% | 67.86% | 26.11% | 83.15% | 160.00% | -3.97% |
| Net Profit | 2.56 | 0.09 | 1.67 | 0.15 | -0.04 | -2.43 |
| EPS in Rs | 5.16 | 0.13 | 2.46 | 0.22 | -0.06 | -3.59 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 55.93 | 49.35 | 39.28 | 46.08 | 44.98 | 41.96 |
| Expenses | 48.68 | 45.98 | 32.02 | 40.08 | 40.10 | 42.26 |
| Operating Profit | 7.25 | 3.37 | 7.26 | 6.00 | 4.88 | -0.30 |
| OPM % | 12.96% | 6.83% | 18.48% | 13.02% | 10.85% | -0.71% |
| Other Income | 0.43 | 0.33 | 0.53 | 0.30 | 0.57 | 0.89 |
| Interest | 0.82 | 0.78 | 0.57 | 0.84 | 0.80 | 1.48 |
| Depreciation | 1.09 | 1.32 | 1.29 | 1.27 | 1.50 | 1.52 |
| Profit before tax | 5.77 | 1.60 | 5.93 | 4.19 | 3.15 | -2.41 |
| Tax % | 26.52% | 28.75% | 28.16% | 29.12% | 42.54% | 2.49% |
| Net Profit | 4.24 | 1.14 | 4.25 | 2.97 | 1.82 | -2.47 |
| EPS in Rs | 4,240.00 | 1,140.00 | 8.57 | 4.38 | 2.69 | -3.65 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -6% | 2% | -7% | ||
| Compounded Profit Growth | % | % | % | -233% | ||
| Stock Price CAGR | % | % | % | -55% | ||
| Return on Equity | % | 10% | 3% | -9% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 6.78 |
| Reserves | 3.85 | 4.70 | 3.81 | 18.07 | 19.94 | 17.48 |
| Borrowings | 14.24 | 12.38 | 11.59 | 11.10 | 10.53 | 27.90 |
| Other Liabilities | 7.17 | 7.40 | 8.55 | 7.91 | 10.75 | 16.28 |
| Total Liabilities | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 68.44 |
| Fixed Assets | 13.84 | 13.40 | 11.60 | 14.32 | 15.26 | 40.81 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.05 |
| Other Assets | 10.36 | 10.77 | 16.63 | 28.07 | 32.70 | 27.58 |
| Total Assets | 25.27 | 24.49 | 28.91 | 43.86 | 48.00 | 68.44 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 4.45 | 0.08 | 2.59 | -2.50 | 5.06 | 8.06 |
| Cash from Investing Activity | -5.07 | -0.02 | 0.36 | -5.44 | -7.37 | -26.74 |
| Cash from Financing Activity | 2.16 | -1.86 | -1.59 | 12.21 | 3.67 | 19.04 |
| Net Cash Flow | 1.55 | -1.80 | 1.36 | 4.27 | 1.36 | 0.36 |
| Free Cash Flow | -1.17 | -0.82 | 3.16 | -4.11 | 2.68 | -19.02 |
| CFO/OP | 77% | 54% | 40% | -12% | 134% | -2,727% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 31.91 | 43.42 | 90.41 | 108.52 | 121.40 | 95.86 |
| Inventory Days | 68.78 | 40.82 | 69.86 | 40.26 | 36.56 | 63.48 |
| Days Payable | 258.06 | 221.84 | 319.59 | 207.25 | 199.54 | 303.03 |
| Cash Conversion Cycle | -157.37 | -137.61 | -159.32 | -58.47 | -41.58 | -143.69 |
| Working Capital Days | -4.11 | 3.11 | 43.12 | 73.43 | 73.68 | -11.05 |
| ROCE % | 12.33% | 32.85% | 17.30% | 10.60% | -1.85% |
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Promoters | 73.11% | 73.11% | 73.11% | 73.00% | 73.11% |
| FIIs | 2.53% | 0.41% | 0.01% | 0.00% | 0.00% |
| DIIs | 1.35% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 23.02% | 26.48% | 26.88% | 27.00% | 26.89% |
| No. of Shareholders | 474 | 907 | 986 | 978 | 976 |
Fundamentals
Market Cap₹ 73.8 Cr.
Current Price₹ 109
Book Value₹ 35.8
ROCE-1.85 %
ROE-9.34 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-7%
Compounded Profit Growth (TTM)-233%
Consolidated figures.
Valuation
Market capRs 80 Cr
Enterprise valueRs 91 Cr
P/E (TTM)69.79x
Price to book16.89x
Price to sales1.61x
EV / EBITDA24.54x
EV / EBIT38.15x
EV / sales1.84x
Price to cash flow994.45x
Earnings yield1.43%
Profitability
Operating margin (excl. other income)6.83%
Operating margin (incl. other income)7.50%
EBITDA margin7.50%
Pre-tax margin3.24%
Net profit margin2.31%
ROE26.60%
ROCE13.53%
ROA4.58%
ROIC (approx.)10.64%
Tax rate28.75%
Other income / net worth7.01%
Growth
Sales growth (latest year)-11.76%
Profit growth (latest year)-73.11%
Per share
EPS (TTM)Rs 1.68
EPS (latest year)Rs 1,140.00
Book value per shareRs 6.95
Sales per shareRs 72.83
Cash flow per shareRs 0.12
Free cash flow per shareRs -28.07
Efficiency
Asset turnover2.02x
Fixed asset turnover3.68x
Inventory turnover21.20x
Inventory days17 days
Debtor days43 days
Debtors turnover8.41x
Creditor days303 days
Cash conversion cycle-144 days
Working capital days-11 days
Leverage
Total debtRs 12 Cr
Cash and bankRs 1 Cr
Net debtRs 11 Cr
Debt to equity2.63x
Net debt / EBITDA3.04x
Interest coverage3.05x
Owners' fund to total sources19.23%
Debt to assets50.55%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -19 Cr
FCFE (approx.: FCF + change in debt)Rs -21 Cr
Cash from ops / profit, 5 years1.72x
Sales to cash flow616.88x
Statement figures
Net sales (TTM)Rs 49 Cr
Net sales (latest year)Rs 49 Cr
Operating profit excl. other income (latest year)Rs 3 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 4 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 15 Cr
Total expenditure (latest year)Rs 46 Cr
Total income (latest year)Rs 50 Cr
Share capitalRs 0 Cr
ReservesRs 5 Cr
Shareholders' fundsRs 5 Cr
Total assetsRs 24 Cr
Net blockRs 13 Cr
InvestmentsRs 0 Cr
ReceivablesRs 6 Cr
InventoryRs 1 Cr
Other liabilitiesRs 7 Cr
Shares outstanding (crore)0.68
Ownership
Promoter holding73.11% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | MAITREYA | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.8% | -2.8% | +3.6 pts |
| 1 month | +3.3% | -6.8% | +10.0 pts |
| 3 months | -18.1% | -7.6% | -10.5 pts |
| 6 months | -46.4% | +0.4% | -46.8 pts |
| 1 year | -49.0% | -9.9% | -39.0 pts |
| 2 years | -6.8% | -13.6% | +6.7 pts |
Red flags
F-score 4 of 8| explain | Receivables outrunning sales Receivables grew 20% vs sales -12% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹21 Cr -8.1% vs Mar 2024.
Net loss ₹2 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
EPS in the scrip is zero (4 trailing quarters)High low price variation greater than 100perc in previous 6 monthsHigh low price variation greater than 150perc in previous 12 monthsLess than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of Maitreya Medicare Ltd?
Maitreya Medicare Ltd (MAITREYA) has a market capitalisation of Rs 73.8 Cr. at the 2026-10-01 close.
What were Maitreya Medicare Ltd's latest quarterly results?
In the Mar 2026 quarter, Maitreya Medicare Ltd sales was Rs 21 Cr (-8.1% vs Mar 2024) with a net loss of Rs 2 Cr.
What is the 52-week high and low of Maitreya Medicare Ltd?
The 52-week high is Rs 292.95 and the 52-week low is Rs 103.10.